Evidence map›Paper›PMID 34968222›Full record

ArticleNursing reports (Pavia, Italy)2021

Brief Report: Hispanic Patients' Trajectory of Cancer Symptom Burden, Depression, Anxiety, and Quality of Life.

Eida M Castro-Figueroa, Normarie Torres-Blasco, Milagros C Rosal, Julio C Jiménez, Wallesca P Castro-Rodríguez, Marilis González-Lorenzo, Héctor Vélez-Cortés, Alia Toro-Bahamonde, Rosario Costas-Muñiz, Guillermo N Armaiz-Peña and 1 more

Abstract read
In one paragraph

Article in Nursing reports (Pavia, Italy), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Eida M Castro-FigueroaPonce Health Sciences University-Ponce Research Institute, Ponce 00716, Puerto Rico.
Normarie Torres-BlascoPonce Health Sciences University-Ponce Research Institute, Ponce 00716, Puerto Rico.
Milagros C RosalPopulation and Quantitative Health Sciences, School of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Julio C JiménezPonce Health Sciences University-Ponce Research Institute, Ponce 00716, Puerto Rico.
Wallesca P Castro-RodríguezChristiana Care Health Center-Helen F. Graham Care Center, Wilmington, DE 19899, USA.
Marilis González-LorenzoPonce Health Sciences University-Ponce Research Institute, Ponce 00716, Puerto Rico.
Héctor Vélez-CortésPonce Health Sciences University-Ponce Research Institute, Ponce 00716, Puerto Rico.
Alia Toro-BahamondeMerck Pharmaceutical, Oncology Department, Kenilworth, NJ 07033, USA.
Rosario Costas-MuñizMemorial Sloan Kettering Cancer Center, Department of Psychiatry and Behavioral Sciences, Puerto Rico, CA 00984, USA.ORCID 0000-0003-0942-5657
Guillermo N Armaiz-PeñaPonce Health Sciences University-Ponce Research Institute, Ponce 00716, Puerto Rico.ORCID 0000-0002-9081-5339
Heather JimMoffitt Cancer Center, Tampa, FL 33612, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
The Role of Midbrain to Prelimbic Cortex Glutamatergic projections in Stress-induced Drug SeekingU54MD007579 · NIMHD · PONCE SCHOOL OF MEDICINE · PI Emmanuel Antonio Cruz, Kenira J Thompson · 2019 to 2026
$35.9M
TECHNOLOGIES AND RESOURCES FOR CORE LABORATORIESU54MD007587 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI LUCIANO, CARLOS A., WOJNA, VALERIE · 2012 to 2018
$23.2M
Using MC1R genotype to impact skin cancer risk behaviors in Hispanics/LatinosU54CA163068 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI Shannon Marie Christy · 2012 to 2026
$23.1M
Using MC1R genotype to impact skin cancer risk behaviors in Hispanics/LatinosU54CA163071 · NCI · PONCE SCHOOL OF MEDICINE · PI Harold I Saavedra · 2012 to 2026
$23.0M
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)U24MD015970 · NIMHD · MOREHOUSE SCHOOL OF MEDICINE · PI Sandra Perreira Chang, Elizabeth O. Ofili · 2020 to 2026
$20.6M
Tracking and Evaluation CoreU54GM133807 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI BONILLA-FELIX, MELVIN · 2020 to 2024
$17.7M
VIRAL SEQUENCES IN PEDIATRIC HIV INFECTION IN PRG12MD007579 · NIMHD · PONCE SCHOOL OF MEDICINE · PI TORRES-RUIZ, JOSE A · 2012 to 2018
$15.9M
Hispanic Clinical and Translational Research Education and Career Development ProgramR25MD007607 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI Karen G. Martinez Gonzalez, Barbara Segarra-Vazquez · 2012 to 2026
$7.4M
UMass Center for Health Equity Intervention ResearchP60MD006912 · NIMHD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ALLISON, JEROAN J · 2012 to 2016
$6.8M
Post-Hurricane Cancer Care: Patient Needs after Hurricane MariaR21MD013674 · NIMHD · PONCE SCHOOL OF MEDICINE · PI CASTRO, EIDA MARIA, JIM, HEATHER S.L. · 2018 to 2022
$2.6M
Cultural Adaptation of IMCP for Latino Patients with Advanced CancerR21CA180831 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI COSTAS-MUNIZ, ROSARIO · 2014 to 2015
$420k
American Cancer Society 133798-PF-19-120-01-CPPBNational Institute of Minority Health and Health Disparities 5G12MD007579National Institute of Minority Health and Health Disparities 5P60MD006912National Institute of Minority Health and Health Disparities 5R25MD007607National Institute of Minority Health and Health Disparities R21MD013674National Institute of Minority Health and Health Disparities U54MD007579NCI NIH HHS 2U54CA163068NCI NIH HHS 2U54CA163071NCI NIH HHS P30 CA008748NCI NIH HHS P30CA008748NCI NIH HHS R21CA180831NIGMS NIH HHS U54 GM133807NIMHD NIH HHS U24 MD015970NIMHD NIH HHS U54 MD007587NIMHD NIH HHS U54MD007587
6 · The paper itself

Abstract

methodsBaseline behavioral assessments were performed before starting chemotherapy. Follow-up behavioral assessments were performed at 3, 6, and 9 months after starting chemotherapy. Descriptive statistics, chi-square tests, Fisher's exact tests, and Mann-Whitney tests explored associations among outcome variables. Adjusted multilevel mixed-effects linear regression models were also used to evaluate the association between HADS scores, follow-up visits, FACT-G scale, MDASI scale, and sociodemographic variables.

resultsIncreased cancer symptom burden was significantly related to changes in anxiety symptoms' scores (adjusted β^ = 0.11 [95% CI: 0.02, 0.19]. Increased quality of life was significantly associated with decreased depression and anxiety symptoms (adjusted β^ = -0.33; 95% CI: -0.47, -0.18, and 0.38 adjusted β^= -0.38; 95% CI: -0.55, -0.20, respectively).

conclusionsFindings highlight the need to conduct periodic mental health screenings among cancer patients initiating cancer treatment.

Indexed as

AnxietyCancerCancer Symptom BurdenDepressionHispanic/LatinxQuality of Life

Identifiers

PMID34968222
PMCPMC8608069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.